Suppr超能文献

免疫调节剂用于破坏性肺结核患者化疗的疗效

The efficiency of chemotherapy with immunomodulators for patients with destructive lung tuberculosis.

作者信息

Khomenko A G, Insanov A B

出版信息

Z Erkr Atmungsorgane. 1986;167(1-2):163-7.

PMID:3765712
Abstract

Immunomodulators are to be prescribed to tuberculous patients in accordance with clinical and immunologic indices for 2 months. Taking into account that levamisol in dose 100 mg/24 hours is well tolerated by the patients and is as efficient as in the dose 150 mg/24 hours it is recommended to use this agent in dose 100 mg/24 hours three times a week. As it became evident from the clinical-roentgenologic, bacteriologic and immunologic data diuciphon is better tolerated by the patients and more efficient than levamisol.

摘要

应根据临床和免疫学指标为结核病患者开具免疫调节剂,疗程为2个月。考虑到患者对24小时100毫克剂量的左旋咪唑耐受性良好,且与24小时150毫克剂量的疗效相同,建议每周三次使用24小时100毫克剂量的该药物。从临床X线、细菌学和免疫学数据来看,双硫芬比左旋咪唑更易被患者耐受且疗效更佳。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验